204 related articles for article (PubMed ID: 7561775)
1. Tripartite genome organization of a natural type 2 vaccine/nonvaccine recombinant poliovirus.
Georgescu MM; Delpeyroux F; Crainic R
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2343-8. PubMed ID: 7561775
[TBL] [Abstract][Full Text] [Related]
2. Natural genetic exchanges between vaccine and wild poliovirus strains in humans.
Guillot S; Caro V; Cuervo N; Korotkova E; Combiescu M; Persu A; Aubert-Combiescu A; Delpeyroux F; Crainic R
J Virol; 2000 Sep; 74(18):8434-43. PubMed ID: 10954543
[TBL] [Abstract][Full Text] [Related]
3. Type 2 poliovirus recombinants isolated from vaccine-associated cases and from healthy contacts in Brazil.
Friedrich F; Da-Silva EF; Schatzmayr HG
Acta Virol; 1996 Feb; 40(1):27-33. PubMed ID: 8886095
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a rare natural intertypic type 2/type 3 penta-recombinant vaccine-derived poliovirus isolated from a child with acute flaccid paralysis.
Zhang Y; Wang H; Zhu S; Li Y; Song L; Liu Y; Liu G; Nishimura Y; Chen L; Yan D; Wang D; An H; Shimizu H; Xu A; Xu W
J Gen Virol; 2010 Feb; 91(Pt 2):421-9. PubMed ID: 19846676
[TBL] [Abstract][Full Text] [Related]
5. Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis.
Furione M; Guillot S; Otelea D; Balanant J; Candrea A; Crainic R
Virology; 1993 Sep; 196(1):199-208. PubMed ID: 8102826
[TBL] [Abstract][Full Text] [Related]
6. Genetic basis of the neurovirulence of type 1 polioviruses isolated from vaccine-associated paralytic patients.
Li J; Zhang LB; Yoneyama T; Yoshida H; Shimizu H; Yoshii K; Hara M; Nomura T; Yoshikura H; Miyamura T; Hagiwara A
Arch Virol; 1996; 141(6):1047-54. PubMed ID: 8712922
[TBL] [Abstract][Full Text] [Related]
7. Common and diverse features of cocirculating type 2 and 3 recombinant vaccine-derived polioviruses isolated from patients with poliomyelitis and healthy children.
Joffret ML; Jégouic S; Bessaud M; Balanant J; Tran C; Caro V; Holmblat B; Razafindratsimandresy R; Reynes JM; Rakoto-Andrianarivelo M; Delpeyroux F
J Infect Dis; 2012 May; 205(9):1363-73. PubMed ID: 22457288
[TBL] [Abstract][Full Text] [Related]
8. Use of mutational pattern in 5'-NCR and VP1 regions of polioviruses for molecular diagnosis.
Pliaka V; Dedepsidis E; Kyriakopoulou Z; Papadopoulou I; Levidiotou S; Markoulatos P
Mol Cell Probes; 2007 Aug; 21(4):267-75. PubMed ID: 17336496
[TBL] [Abstract][Full Text] [Related]
9. Manipulation of the cellular binding properties of poliovirus: implications for non-target effects of recombinant vaccines.
Whelan SP; Evans D; Almond JW
Dev Biol Stand; 1995; 84():129-36. PubMed ID: 7796945
[No Abstract] [Full Text] [Related]
10. High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis.
Georgescu MM; Delpeyroux F; Tardy-Panit M; Balanant J; Combiescu M; Combiescu AA; Guillot S; Crainic R
J Virol; 1994 Dec; 68(12):8089-101. PubMed ID: 7966599
[TBL] [Abstract][Full Text] [Related]
11. Genetic divergence of poliovirus strains isolated in the Karachi region of Pakistan.
Huovilainen A; Mulders MN; Agboatwalla M; Pöyry T; Stenvik M; Hovi T
J Gen Virol; 1995 Dec; 76 ( Pt 12)():3079-88. PubMed ID: 8847513
[TBL] [Abstract][Full Text] [Related]
12. Rare natural type 3/type 2 intertypic capsid recombinant vaccine-related poliovirus isolated from a case of acute flaccid paralysis in Brazil, 2015.
Cassemiro KMSM; Burlandy FM; da Silva EE
J Gen Virol; 2016 Jul; 97(7):1545-1550. PubMed ID: 27082658
[TBL] [Abstract][Full Text] [Related]
13. Genomic characterization of type 3 polioviruses isolated from vaccine-associated poliomyelitis cases in Brazil.
Friedrich F; Filippis AM; Ferreira FC; Schatzmayr HG; Da-Silva EE
Braz J Med Biol Res; 1995 Feb; 28(2):195-200. PubMed ID: 7581041
[TBL] [Abstract][Full Text] [Related]
14. Genetic features of polioviruses isolated in Tunisia, 1991-2006.
Haddad-Boubaker S; Ben Yahia A; Bahri O; Morel V; Balanant J; Delpeyroux F; Triki H
J Clin Virol; 2008 Feb; 41(2):81-6. PubMed ID: 18023246
[TBL] [Abstract][Full Text] [Related]
15. Genomic characterization of type 2 polioviruses isolated from vaccine-associated cases in Brazil.
Friedrich F; Filippis AM; Ferreira FC; Schatzmayr HG; Da-Silva EE
Braz J Med Biol Res; 1995 Jul; 28(7):733-42. PubMed ID: 8580863
[TBL] [Abstract][Full Text] [Related]
16. Random selection: a model for poliovirus infection of the central nervous system.
Georgescu MM; Balanant J; Ozden S; Crainic R
J Gen Virol; 1997 Aug; 78 ( Pt 8)():1819-28. PubMed ID: 9266975
[TBL] [Abstract][Full Text] [Related]
17. Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model.
Gavrilin GV; Cherkasova EA; Lipskaya GY; Kew OM; Agol VI
J Virol; 2000 Aug; 74(16):7381-90. PubMed ID: 10906191
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of poliovirus isolates from children who contracted vaccine-associated paralytic poliomyelitis (VAPP) following administration of monovalent type 3 oral poliovirus vaccine in the 1960s in Hungary.
Kapusinszky B; Molnár Z; Szomor KN; Berencsi G
FEMS Immunol Med Microbiol; 2010 Mar; 58(2):211-7. PubMed ID: 19863665
[TBL] [Abstract][Full Text] [Related]
19. Circulation of a type 1 recombinant vaccine-derived poliovirus strain in a limited area in Romania.
Combiescu M; Guillot S; Persu A; Baicus A; Pitigoi D; Balanant J; Oprisan G; Crainic R; Delpeyroux F; Aubert-Combiescu A
Arch Virol; 2007; 152(4):727-38. PubMed ID: 17195957
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1.
Blomqvist S; Bruu AL; Stenvik M; Hovi T
J Gen Virol; 2003 Mar; 84(Pt 3):573-580. PubMed ID: 12604808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
